Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives

Details for Australian Patent Application No. 2001268727 (hide)

Owner Bristol-Myers Squibb Company

Inventors Yin, Zhiwei; Xue, Qiufen May; Fang, Haiquan; Qiu, Zhilei; Meanwell, Nicholas A.; Pearce, Bradley C.; Yeung, Kap-Sun; Wang, Tao; Wallace, Owen B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001268727

PCT Pub. Number WO02/04440

Priority 60217444 10.07.00 US; 60265978 02.02.01 US

Filing date 26 June 2001

Wipo publication date 21 January 2002

Acceptance publication date 24 March 2005

International Classifications

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61P 003/12 Drugs for disorders of the metabolism

A61P 003/00 Drugs for disorders of the metabolism

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

Event Publications

24 March 2005 Application Accepted

  Published as AU-B-2001268727

21 July 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001268728

2001268726